Medavail Stock Analysis

MDVL -  USA Stock  

USD 1.39  0.02  1.42%

The big decline in price over the last few months for Medavail Hldgmay encourage stakeholders to take a closer look at the firm as it is trading at a share price of 1.39 on 56,800 in trading volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Medavail Hldg or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.54. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Medavail Hldg partners.
Additionally, see Stocks Correlation.

Medavail Stock Analysis 

The Medavail Hldg stock analysis report makes it easy to digest most publicly released information about Medavail Hldg and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Medavail Stock analysis module also helps to analyze the Medavail Hldg price relationship with some important fundamental indicators such as market cap and management efficiency.

Medavail Stock Analysis Notes

About 85.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.46. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medavail Hldg recorded a loss per share of 1.51. The entity had not issued any dividends in recent years. The firm had 1-12 split on the 18th of November 2020. MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. Medavail Hldg operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 224 people. To find out more about Medavail Hldg contact the company at 905 812 0023 or learn more at

Medavail Hldg Quarterly Cost of Revenue

5.61 MillionShare

Medavail Hldg Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Medavail Hldg's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Medavail Hldg or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Medavail Hldg generated a negative expected return over the last 90 days
Medavail Hldg has high historical volatility and very poor performance
Medavail Hldg may become a speculative penny stock
Medavail Hldg has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 17.95 M. Net Loss for the year was (43.28 M) with profit before overhead, payroll, taxes, and interest of 5.16 M.
Medavail Hldg currently holds about 35.88 M in cash with (41.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.09.
Medavail Hldg has a frail financial position based on the latest SEC disclosures
Over 85.0% of the company shares are owned by institutional investors
Latest headline from Is Medavail Holdings Inc a Stock to Watch After Losing 0.00 percent This Week - InvestorsObserver

Medavail Hldg Upcoming and Recent Events

Earnings reports are used by Medavail Hldg to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Medavail Hldg previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report29th of March 2022
Next Earnings Report11th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End29th of March 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Medavail Hldg SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Medavail Hldg prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Medavail Hldg investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Medavail Hldg specific information freely available to individual and institutional investors to make a timely investment decision.
14th of January 2022
Unclassified Corporate Event
11th of January 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
29th of November 2021
Unclassified Corporate Event
8th of November 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
25th of October 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
30th of September 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
20th of September 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
10th of September 2021
Financial Statements and Exhibits. Regulation FD Disclosure

Medavail Hldg Thematic Classifications

In addition to having Medavail Hldg stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products IdeaPharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Medavail Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 45.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medavail Hldg's market, we take the total number of its shares issued and multiply it by Medavail Hldg's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Medavail Profitablity

Medavail Hldg's profitability indicators refer to fundamental financial ratios that showcase Medavail Hldg's ability to generate income relative to its revenue or operating costs. If, let's say, Medavail Hldg is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Medavail Hldg's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Medavail Hldg's profitability requires more research than a typical breakdown of Medavail Hldg's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (241.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (226.93) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -2.27.
Last ReportedProjected for 2022
Return on Average Assets(1.20) (1.29) 
Return on Average Equity(1.80) (1.94) 
Return on Invested Capital(8.82) (9.52) 
Return on Sales(2.11) (2.27) 

Management Efficiency

The entity has return on total asset (ROA) of (41.93) % which means that it has lost $41.93 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (93.81) %, meaning that it created substantial loss on money invested by shareholders. Medavail Hldg management efficiency ratios could be used to measure how well medavail hldg manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return on Average Assets is estimated to pull down to -1.29. The value of Return on Average Equity is estimated to pull down to -1.94. Medavail Hldg Asset Turnover is relatively stable at the moment as compared to the past year. The company's current value of Asset Turnover is estimated at 0.86. Tangible Assets Book Value per Share is expected to hike to 11.12 this year, although the value of Return on Average Assets will most likely fall to (1.29) .
Last ReportedProjected for 2022
Book Value per Share 9.60  8.51 
Enterprise Value over EBIT(17.10) (17.55) 
Enterprise Value over EBITDA(18.08) (18.56) 
Price to Book Value 7.03  7.58 
Tangible Assets Book Value per Share 10.87  11.12 
Enterprise Value549 M592.4 M
Tangible Asset Value79.5 M85.7 M

Technical Drivers

As of the 25th of January, Medavail Hldg secures the risk adjusted performance of (0.10), and Mean Deviation of 4.34. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medavail Hldg, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Medavail Hldg, which can be compared to its peers in the industry. Please verify Medavail Hldg variance, as well as the relationship between the value at risk and skewness to decide if Medavail Hldg is priced some-what accurately, providing market reflects its recent price of 1.39 per share. Given that Medavail Hldg is a hitting penny stock territory we strongly suggest to closely look at its total risk alpha.

Medavail Hldg Price Movement Analysis

The output start index for this execution was one with a total number of output elements of sixty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Medavail Hldg middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Medavail Hldg. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Medavail Hldg Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medavail Hldg insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medavail Hldg's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medavail Hldg insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Medavail Hldg Predictive Daily Indicators

Medavail Hldg intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medavail Hldg stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Medavail Hldg Forecast Models

Medavail Hldg time-series forecasting models is one of many Medavail Hldg's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medavail Hldg's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Medavail Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Medavail Hldg stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medavail shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Medavail Hldg. By using and applying Medavail Stock analysis, traders can create a robust methodology for identifying Medavail entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(1.96) (2.11) 
Gross Margin 0.43  0.46 
Profit Margin(2.21) (2.38) 
MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. Medavail Hldg operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 224 people.

Current Medavail Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Medavail analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Medavail analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
7.0Strong Buy1Odds
Medavail Hldg current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Medavail analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Medavail stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Medavail Hldg, talking to its executives and customers, or listening to Medavail conference calls.
Medavail Analyst Advice Details

Medavail Stock Analysis Indicators

Medavail Hldg stock analysis indicators help investors evaluate how Medavail Hldg stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Medavail Hldg shares will generate the highest return on investment. By understating and applying Medavail Hldg stock analysis, traders can identify Medavail Hldg position entry and exit signals to maximize returns.
Quick Ratio4.05
Fifty Two Week Low1.1700
Revenue Growth-18.90%
Shares Short Prior Month469.47k
Average Daily Volume Last 10 Day371.43k
Average Daily Volume In Three Month200.58k
Shares Percent Shares Out1.66%
Gross Margins2.41%
Short Percent Of Float3.81%
Forward Price Earnings-0.98
Float Shares11.88M
Fifty Two Week High17.4800
Enterprise Value To Ebitda-0.60
Fifty Day Average1.6160
Two Hundred Day Average6.4956
Enterprise Value To Revenue1.28
Additionally, see Stocks Correlation. Note that the Medavail Hldg information on this page should be used as a complementary analysis to other Medavail Hldg's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Medavail Stock analysis

When running Medavail Hldg price analysis, check to measure Medavail Hldg's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medavail Hldg is operating at the current time. Most of Medavail Hldg's value examination focuses on studying past and present price action to predict the probability of Medavail Hldg's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Medavail Hldg's price. Additionally, you may evaluate how the addition of Medavail Hldg to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Is Medavail Hldg's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medavail Hldg. If investors know Medavail will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medavail Hldg listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Medavail Hldg is measured differently than its book value, which is the value of Medavail that is recorded on the company's balance sheet. Investors also form their own opinion of Medavail Hldg's value that differs from its market value or its book value, called intrinsic value, which is Medavail Hldg's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medavail Hldg's market value can be influenced by many factors that don't directly affect Medavail Hldg's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medavail Hldg's value and its price as these two are different measures arrived at by different means. Investors typically determine Medavail Hldg value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medavail Hldg's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.